| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 83476 |
SPDP-Val-Cit-PAB-OH(N-琥珀酰亚胺基-3-(2-吡啶二硫)丙酸) |
94 |
WYQ |
2024-12-18 |
| 83477 |
鹿茸多肽脂质体,Velvet,antler,peptides,liposome,VAP-Lip,多功能载药脂质体定制服务 |
164 |
axc |
2024-12-18 |
| 83478 |
NOTA-西妥昔单抗-800CW NOTA-cetuximab-800CW |
106 |
h |
2024-12-18 |
| 83479 |
CAS:644981-35-1,Val-Cit-PAB-MMAE , ADC试剂 |
109 |
kx |
2024-12-18 |
| 83480 |
SPDP-Val-Cit-PAB-PNP,分子式:C33H39N7O9S2 |
127 |
WYQ |
2024-12-18 |
| 83481 |
Azido-PEG4-Ala-Ala-Asn(Trt)-PAB(CAS:2055042-67-4) |
180 |
WYQ |
2024-12-18 |
| 83482 |
负载黄芩苷脂质体的纳米纤维膜,BCL-LPs/PVA-CS,NFs,载药脂质体定制服务 |
191 |
axc |
2024-12-18 |
| 83483 |
Auristatin E(CAS:160800-57-7),澳瑞他汀E |
127 |
WYQ |
2024-12-18 |
| 83484 |
Amino-PEG10-C6 氨基-聚乙二醇10-C6 |
115 |
zyl |
2024-12-18 |
| 83485 |
2762519-08-2,endo-BCN-PEG4-Val-Cit-PAB-MMAE,(1R,8S,9S)-双环[6.1.0]壬-四聚乙二醇-VAL-CIT-PAB-MMAE |
103 |
kx |
2024-12-18 |
| 83486 |
MMAE(CAS:474645-27-7),一甲基澳瑞他汀E,Monomethyl auristatin E |
317 |
WYQ |
2024-12-18 |
| 83487 |
m-PEG1-C11-SH,117559-62-3,甲基-一聚乙二醇-C11-巯基 |
111 |
zyl |
2024-12-18 |
| 83488 |
CAS:1703768-74-4,Vipivotide tetraxetan Linker , ADC试剂 |
110 |
kx |
2024-12-18 |
| 83489 |
Thalidomide-O-Cn-NH2,沙利度胺-烷基链-氨基 |
117 |
zyl |
2024-12-18 |
| 83490 |
Mal-amido-PEG8-val-gly-PAB-OH CAS号:2353409-52-4 |
117 |
WYQ |
2024-12-18 |
| 83491 |
cas:1042435-35-7,2-(2-(2-(3-((2,5-Dioxopyrrolidin-1-yl)oxy)-3-oxopropoxy)ethoxy)ethoxy)ethyl acrylate,ADC定制 |
230 |
wyh |
2024-12-18 |
| 83492 |
Fmoc-PEG4-Ala-Ala-Asn-PAB,CAS号:2055048-57-0 |
116 |
WYQ |
2024-12-18 |
| 83493 |
CAS:1116086-09-9,Fmoc-Phe -Lys(Trt)-PAB-PNP , ADC试剂 |
112 |
kx |
2024-12-18 |
| 83494 |
DBCO-C12-amine 二苯并环辛炔-C12-胺 |
99 |
zyl |
2024-12-18 |
| 83495 |
Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB,CAS号:2055042-69-6 |
143 |
WYQ |
2024-12-18 |
| 83496 |
C14-494 Lipid B4 CAS:2639634-80-1 |
115 |
zyl |
2024-12-18 |
| 83497 |
NOTA-ZnPc缀合物 水溶性磺化锌酞菁缀合1,4,7-三氮杂环壬烷-1,4,7-三乙酸(NOTA) |
108 |
h |
2024-12-18 |
| 83498 |
cas:663598-66-1,NO2-SPP-sulfo,ADC定制 |
105 |
wyh |
2024-12-18 |
| 83499 |
Val-Cit-PAB-MMAE(CAS:644981-35-1) |
151 |
WYQ |
2024-12-18 |
| 83500 |
NOTA-D-Phe-Gln-Trp-Ala-Val-Gly-His-Leu-nhch 2ch3 NOTA-atbbn |
115 |
h |
2024-12-18 |
| 83501 |
MAL-tetra-EG-OPFP,ADC定制 |
141 |
kx |
2024-12-18 |
| 83502 |
MC-Val-Cit-PAB-MMAE(CAS:646502-53-6) |
135 |
WYQ |
2024-12-18 |
| 83503 |
Fmoc-Val-Cit-PAB-MMAE(CAS:1350456-56-2) |
99 |
WYQ |
2024-12-18 |
| 83504 |
NOTA-VHH-Za 融合蛋白VHH-Zag偶联双功能螯合剂NOTA |
124 |
h |
2024-12-18 |
| 83505 |
Py-ds-Prp-OSu, ADC试剂 |
192 |
kx |
2024-12-18 |
| 83506 |
MMA-NOTA 马来酰亚胺单酰胺缀合1,4,7-三氮杂壬烷-1,4,7-三酰基)三乙酸 |
144 |
h |
2024-12-18 |
| 83507 |
辣根过氧化氢酶-棕榈酸 HRP-C16 palmitic acid |
124 |
zyl |
2024-12-18 |
| 83508 |
CAS:187794-49-6,Boc-Gly-Gly-Phe-Gly-OH,叔丁酯-GLY-GLY-PHE-GLY-羟基 |
107 |
kx |
2024-12-18 |
| 83509 |
C18-PEG5000-NHS 活性酯PEG十八烷基 |
126 |
zyl |
2024-12-18 |
| 83510 |
cas:1006592-59-1,Propargyl-C8-amido-PEG2-NHS ester,ADC定制 |
104 |
wyh |
2024-12-18 |
| 83511 |
N-Hydroxysulfosuccinimide sodium(CAS:106627-54-7) |
106 |
WYQ |
2024-12-18 |
| 83512 |
Vipivotide tetraxetan Linker(CAS:1703768-74-4) |
92 |
WYQ |
2024-12-18 |
| 83513 |
CAS:2395887-69-9,Mal-PEG2-VCP-NB ,马来酰亚胺-二聚乙二醇-VAL-CIT-PAB-PNP 酯 |
100 |
kx |
2024-12-18 |
| 83514 |
MAC glucuronide linker-2(CAS:229977-57-5) |
100 |
WYQ |
2024-12-18 |
| 83515 |
cas:102814-00-6,(2S,2'S)-Bis(2,5-dioxopyrrolidin-1-yl) 4,4'-disulfanediylbis(2-acetamidobutanoate),ADC定制 |
104 |
wyh |
2024-12-18 |
| 83516 |
Fmoc-Val-Cit-PAB-MMAE(CAS:1350456-56-2) |
136 |
WYQ |
2024-12-18 |
| 83517 |
CAS:1646299-50-4,Fmoc-Phe-Lys(Boc)-PAB-PNP , ADC试剂 |
105 |
kx |
2024-12-18 |
| 83518 |
C18-PEG-AC 十八烷基-聚乙二醇-丙烯酸 |
112 |
zyl |
2024-12-18 |
| 83519 |
Amino-PEG4-Val-Cit-PAB-MMAE(CAS:1492056-71-9) |
97 |
WYQ |
2024-12-18 |
| 83520 |
Azido-PEG4-Val-Cit-PAB-MMAE(CAS:1869126-64-6) |
102 |
WYQ |
2024-12-18 |